EP
BSX icon

Eudaimonia Partners’s Boston Scientific BSX Stock Holding History

Eudaimonia Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,109
Closed -$120K – 499
2021
Q1 		$120K Hold
3,109
– – 0.02% 437
2020
Q4 		$112K Buy
3,109
+150
+5% +$5.41K 0.03% 425
2020
Q3 		$113K Buy
2,959
+225
+8% +$8.67K 0.03% 380
2020
Q2 		$96K Sell
2,734
-59
-2% -$2.13K 0.04% 366
2020
Q1 		$91K Sell
2,793
-20
-0.7% -$781 0.04% 351
2019
Q4 		$127K Buy
+2,813
New +$118K 0.05% 309

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Eudaimonia Partners's BSX Position: Q2 2021 in Review

Eudaimonia Partners sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 3,109 shares — an estimated $120K sold.

Eudaimonia Partners first reported a position in BSX in Q4 2019 and held it in 6 quarters. The position peaked at $127K in Q4 2019. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Eudaimonia Partners reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 3,109 Boston Scientific shares in Q2 2021, an estimated $120K.
  • Eudaimonia Partners first reported a position in Boston Scientific in Q4 2019 and held it in 6 quarters.
  • Eudaimonia Partners's Boston Scientific position peaked at $127K in Q4 2019.
  • 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.